Delhi HC directs Lava to deposit ₹20 crore as pro tem security in Dolby’s SEP infringement suit involving AAC audio tech patents.
Read more about Dolby v. Lava: INR 20 Crore Deposit Ordered in SEP patent infringement caseTag: patent infringement
Who Bears the Patent Credibility Challenge Burden?
Mold Tek filed a case for infringement of its patents relating to tamper-proof plastic lids, and secured an interim injunction. The Commercial Court vacated the injunction, placing the burden of establishing validity on the patentee. The Delhi High Court reversed this, clarifying that it is the defendant’s burden to raise a credible invalidity defence under Section 107.
Read more about Who Bears the Patent Credibility Challenge Burden?Patent Upheld, Design Dismissed: Dura-Line vs. Jain Irrigation – Part 1: Infringement & Relief
This post analyzes the Delhi High Court’s decision in Dura-Line vs. Jain Irrigation, where the Court found patent infringement but rejected the design infringement claim.
Read more about Patent Upheld, Design Dismissed: Dura-Line vs. Jain Irrigation – Part 1: Infringement & ReliefWhen Dye Becomes Decisive: Patent Infringement, Equivalence, and Estoppel
In a patent infringement case, the Delhi High Court denied Crystal Crop Protection’s request for an interim injunction against Safex Chemicals. The dispute in the case centred on a herbicidal formulation containing Clodinafop, Metribuzin, and a dyeing agent. The Court held that the dye was an essential claim element and that Safex’s dye-free products did not infringe, even by equivalence. It also invoked prosecution history estoppel, noting that Crystal’s own claim amendments precluded a broad claim interpretation.
Read more about When Dye Becomes Decisive: Patent Infringement, Equivalence, and EstoppelMadras High Court Dismisses Patent Infringement Suit, Allows Coexistence of Technologies
The Madras High Court ruled on a patent infringement dispute involving Arumugam Rajendra Babu and Ashok Leyland over battery-swapping technology. The Court found no infringement and dismissed both the suit and counterclaims, allowing both parties to coexist. The ruling addressed prior art, novelty, and the scope of patent protection in the electric vehicle sector.
Read more about Madras High Court Dismisses Patent Infringement Suit, Allows Coexistence of TechnologiesCourt refuses interim injunction based on Patent Prosecution History
The Delhi High Court refused an interim injunction in a patent dispute over a fuel cap, citing ambiguous claims and prosecution history. The judgment highlights the need for precise claim drafting and careful interpretation in patent litigation.
Read more about Court refuses interim injunction based on Patent Prosecution HistoryClarifying Product-by-Process Patent Claims in India – West Bengal Chemicals v. GTZ
The Calcutta High Court has clarified the standards for product-by-process patent claims in India, focusing on the necessity of expert evidence in infringement cases. The decision in West Bengal Chemicals v. GTZ provides important guidance for pharmaceutical patent litigation.
Read more about Clarifying Product-by-Process Patent Claims in India – West Bengal Chemicals v. GTZCool interim order for ITW’s pre-conditioned air patent, but Competitor’s airport deals allowed to continue
The Delhi High Court issued a significant interim injunction in the ITW pre-conditioned air patent dispute, focusing on inventive step and claim construction under Indian law. While ITW secured a ban on future infringing acts, Dabico’s existing airport deployments were allowed to proceed.
Read more about Cool interim order for ITW’s pre-conditioned air patent, but Competitor’s airport deals allowed to continueBoehringer secures Patent Injunction for its Diabetes Drug – Empagliflozin
The Himachal Pradesh High Court has granted Boehringer Ingelheim an interim injunction against Eris Lifesciences, preventing the manufacture and sale of Empagliflozin during the suit. The case provides insights into the judicial approach towards pharmaceutical patent disputes in India.
Read more about Boehringer secures Patent Injunction for its Diabetes Drug – EmpagliflozinStandard Essential Patents, Claim charts and Infringement – Ericsson v. Lava – Part 4
This post discusses how the Delhi High Court assessed infringement of standard essential patents in Ericsson v. Lava, evaluating claim charts and the two-step infringement test. The court’s structured approach clarifies key aspects of SEP litigation in India.
Read more about Standard Essential Patents, Claim charts and Infringement – Ericsson v. Lava – Part 4